Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Linhua Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2322-4050; OpenAlex author ID A5071722049. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 4

  1. PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma. Co-author DOI 10.1186/s12876-022-02609-y↗
  2. The RNA methyltransferase NSUN6 suppresses pancreatic cancer development by regulating cell proliferation. Co-author DOI 10.1016/j.ebiom.2020.103195↗
  3. miR-3613-5p enhances the metastasis of pancreatic cancer by targeting CDK6. Last author DOI 10.1080/15384101.2020.1831254↗
  4. miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis. Co-author DOI 10.1038/cddis.2017.530↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ming Zhan · 3 shared papers, 2017–2021 · strength 0.31
  2. Ruimeng Yang · 3 shared papers, 2017–2021 · strength 0.31
  3. Xing Liang · 2 shared papers, 2021–2023 · strength 0.31
  4. Manmei Long · 2 shared papers, 2017–2020 · strength 0.18
  5. Anan Liu · 1 shared paper, 2023 · strength 0.18
  6. Xiaoqiang Dong · 1 shared paper, 2023 · strength 0.18
  7. Zhiping Fu · 1 shared paper, 2023 · strength 0.18
  8. Chenghao Shao · 1 shared paper, 2023 · strength 0.18
  9. Yongwei Sun · 1 shared paper, 2021 · strength 0.13
  10. Hui Wang · 1 shared paper, 2020 · strength 0.11
  11. Rong Yue Cao · 1 shared paper, 2020 · strength 0.11
  12. Shuai Huang · 1 shared paper, 2017 · strength 0.06
  13. Jian Wang · 1 shared paper, 2017 · strength 0.06
  14. Qiang Liu · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.